Maulik Nanavaty - 28 May 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Svai Sanford, Attorney-in-Fact for Maulik Nanavaty
Issuer symbol
RANI
Transactions as of
28 May 2025
Transactions value $
$0
Form type
4
Filing time
30 May 2025, 17:59:04 UTC
Previous filing
17 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nanavaty Maulik Director C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE /s/ Svai Sanford, Attorney-in-Fact for Maulik Nanavaty 30 May 2025 0001529708

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Director Stock Option (Right to Buy) Award $0 +50K $0.00 50K 28 May 2025 Class A Common Stock 50K $0.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).